EXEL Exelixis
$64.63 -1.82%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Point at or drag across the chart to read a day. EOD data.
1D
-1.82%
YTD
+47.50%
P/E
18.29
P/B
5.44
ROE
45.5%
Div yield
—
Beta
0.65
Market cap
$16.2B
RSI (14)
43
Next earnings
Feb 8, 2027
Same sector · Health Care
Compare EXEL with NVO and JNJ →Follow EXEL in the AlfaCat app
Watchlist, price and earnings alerts, the chart offline. Free, no account, no ads.
The economy behind it · United States
Economy this week on BullDozer →GDP, % on year
2.1
Q3 2026
Inflation, %
3.7
Sep 2026
Unemployment, %
3.9
Oct 2026
10-yr yield, %
5.13
Oct 2026
From BullDozer, our sister site for country statistics (open sources: OECD, IMF, Eurostat, ILO). Full United States profile →
Previous session
close of Nov 20, 2026 · EOD, no live order bookOpen
$65.95
Close
$64.63
Day high
$66.94
Day low
$64.45
Volume
2.2M
Latest headlines
Exelixis (EXEL) Trades 11% Above Fair Value As Pipeline Hopes Build
Yahoo Finance · Nov 19
Exelixis (EXEL) Stock May Be Below Fair Value After Cancer Study Data
Yahoo Finance · Nov 19
Should You Buy Exelixis Stock For Its Cash?
Yahoo Finance · Nov 19
Exelixis Eyes Q1 Zanza Data as It Plans Beyond CABO
Yahoo Finance · Nov 19
Where Will Exelixis Be in 5 Years? 1 Experimental Drug Could Change Everything
Yahoo Finance · Nov 16
Exelixis Has 2 Major Catalysts Coming by March 2027. Here's What Investors Should Watch.
Yahoo Finance · Nov 13
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
10-Q Oct 29, 2026 View → 8-K Oct 29, 2026 View → 8-K Sep 11, 2026 View → 8-K Aug 31, 2026 View → 10-Q Aug 5, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell EXEL. Try it in the Lab to size a position and see the risk.